---
$id: https://graph.org.ai/products/commodity/51283207
$type: Product
source: UNSPSC
code: "51283207"
title: "Sedecamycin"
class: "51283200"
classTitle: "Macrolides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sedecamycin

**UNSPSC Code**: 51283207
**Class**: [Macrolides](Macrolides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic with the molecular formula C27H35NO8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WLK252Z51F, chemically known as pyruvamide, n-(7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-2-yl)-, 13-acetate, (all-e)-(1s,2r,7s,13s,15r,19r)-(-)- but generally known as sedecamycin, which bears US NIH Compound Identifier 5382567. European Medicines Agency schedules Sedecamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10471MIG. The term SEDECAMYCIN is an International Non-Proprietary Name. SEDECAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sedecamycin under HS 29419000 and SITC 54139. As of Q4 2014, SEDECAMYCIN remains the US FDA Preferred Term for this commodity. Sedecamycin bears US NLM identifiers UMLS ID C0074263 and NCI Concept Code C72589. SMILES: O1C2C(C(=O)C(C(NC(=O)C(=O)C)C=C(C)C=CC(O)CC=C(C=CC(OC(=O)C)C2)C)(C1=O)C)C.

